Trial intelligence / Profile preview

Atorvastatin dose comparison for carotid plaque inflammation assessed by USPIO-enhanced MRI

2005-005703-42Phase 2Completed

Sponsor
GSK
Start
Feb 2006
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial of atorvastatin in carotid atheroma (CAS) (2 arms), sponsored by GSK. Started Feb 2006; status: completed.

02

Drugs

atorvastatin
03

Conditions

carotid atheroma (CAS)

Beyond the preview

Go deeper on 2005-005703-42.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-005703-42.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call